22nd Century Group logo
22nd Century Group XXII
$ 0.71 -14.83%

Quarterly report 2025-Q3
added 11-04-2025

report update icon

22nd Century Group Total Current Liabilities 2011-2026 | XXII

Annual Total Current Liabilities 22nd Century Group

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
25 M 13 M 8.43 M 7.34 M 5.78 M 5.17 M 4.31 M 3.25 M 3.24 M 2.67 M 984 K 4.6 M 2.87 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
25 M 984 K 6.67 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Adagene Adagene
ADAG
38.2 M $ 2.62 28.82 % $ 147 M chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
174 M $ 25.92 -0.86 % $ 1.26 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
344 M $ 24.45 4.49 % $ 2.21 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
BioXcel Therapeutics BioXcel Therapeutics
BTAI
22.2 M $ 1.84 1.66 % $ 4.66 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.66 -1.85 % $ 16.7 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
195 M $ 67.49 -3.02 % $ 9.03 B usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.51 8.41 % $ 9.81 B israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.21 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
3.77 M - -9.72 % $ 5.89 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
332 M $ 2.04 28.3 % $ 192 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Biogen Biogen
BIIB
5.53 B $ 171.89 -1.1 % $ 25 B usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
1.91 M - - $ 100 K usaUSA
BioVie BioVie
BIVI
2.27 M $ 1.2 -3.7 % $ 1.77 M usaUSA